ECL Western Blotting Substrate: Practical Guide

2026-09-14

ECL Western Blotting Substrate (SKU K2187) provides nonradioactive, luminol-based detection of HRP-labeled proteins on immunoblots, with compatibility for X-ray film and CCD imaging. It is intended for chemiluminescent Western blot workflows and should not be used as a fluorescent or radioisotopic detection reagent.

Protein A/G Magnetic Beads for IVDD Assays

2026-09-14

Protein A/G Magnetic Beads provide a focused route to test MAPK1/HMOX1-associated mechanisms in intervertebral disc degeneration. This guide translates recent acacetin research into rigorous immunoprecipitation, co-IP, and chromatin-assay decisions while defining essential controls and limitations.

Protein A/G Magnetic Beads for PTM Research

2026-09-13

Protein A/G Magnetic Beads streamline antibody capture, co-immunoprecipitation, and chromatin workflows when low background and reproducible handling matter. This guide translates the TPM3–HDAC3 vascular study into practical assay designs for post-translational modification and protein-interaction research.

Dual OXPHOS Disruption by LRPPRC Inhibition and Dasatinib

2026-09-12

The reference study identifies dasatinib as a synergistic partner for LRPPRC inhibition and proposes a dual-genome mechanism for suppressing tumor-cell oxidative phosphorylation. Its findings connect mitochondrial transcript destabilization with inhibition of nuclear-encoded OXPHOS programs, while also providing a rationale for biomarker-guided combination studies in LRPPRC-high cancers.

Homoharringtonine Against SARS-CoV-2: Evidence Review

2026-09-12

The reference study presents Homoharringtonine as a host-translation inhibitor with activity against four tested coronaviruses, including SARS-CoV-2, and examines nasal delivery in mice and early patient cohorts. Its central contribution is a translational framework for rapid upper-respiratory-tract viral suppression, while the small, non-comparative clinical datasets require cautious interpretation.

N-Formimidoyl Thienamycin: Spectrum and Bactericidal Action

2026-09-11

The 1982 reference study compared N-formimidoyl thienamycin (MK0787) with several contemporary β-lactam antibiotics across resistant clinical isolates. Its main contribution was to connect broad in vitro activity with bactericidal behavior and apparent independence from β-lactamase production, while also defining organism-specific differences that remain relevant to antibiotic resistance research.

Gut Microbiota, RPE/Choroid, and AMD Pathobiology

2026-09-11

Torin2 Workflow for mTOR Inhibition

2026-09-10

Torin2 enables precise interrogation of mTOR-dependent signaling, viability, migration, and treatment response in cancer models. This workflow pairs pathway measurements with fractional viability and apoptosis assays so growth arrest is not mistaken for cell death.

TUDCA at the Autophagy–ER Stress Interface

2026-09-10

A mechanistic framework for using Tauroursodeoxycholic Acid to investigate how ER stress, mitochondrial injury, apoptosis, and defective autophagy converge in metabolic liver disease. Building on evidence that galectin-1 disrupts the FIP200-centered autophagy machinery in NAFLD models, this article outlines how TUDCA can serve as a pathway-dissection reagent—without being mistaken for a direct Gal-1–FIP200 inhibitor—and provides a translational workflow for metabolic, neurodegenerative, ischemic, and regenerative research.

NBC19: NLRP3 Inflammasome Inhibitor Guide

2026-09-09

NBC19 is a NLRP3 inflammasome inhibitor with reported nanomolar activity in differentiated THP-1 cells. Product data report a 60 nM cellular IC50 and inhibition of Nigericin- and ATP-induced IL-1β release, making NBC19 a research tool for inflammasome and inflammation research.

Methylprednisolone: Mechanism and Bone Evidence

2026-09-09

Methylprednisolone is a synthetic glucocorticoid receptor agonist with anti-inflammatory activity. A rat study used methylprednisolone to model glucocorticoid-induced osteonecrosis of the femoral head and measured bone, vascular, histologic, and osteoclast-related outcomes.

Bestatin-Derived Inhibitors of IRAP and ERAP1

2026-09-08

The reference study establishes a stereoselective route for modifying the α-hydroxy-β-amino acid scaffold of Bestatin and identifies selective inhibitors of the M1 aminopeptidases IRAP, ERAP1, and ERAP2. Structural and cellular data show that interactions with the GAMEN loop, rather than zinc coordination alone, can drive low-nanomolar IRAP inhibition and substantial selectivity.

Fumagillin Workflows for Angiogenesis Research

2026-09-07

Build reproducible Fumagillin assays for endothelial cell proliferation inhibition, tumor-induced angiogenesis studies, and comparative antiparasitic screening. This guide connects MetAP-2 biology with practical formulation, controls, readouts, and troubleshooting decisions.

β-Elemene Inhibits Adipogenesis Through AMPK

2026-09-07

The reference study shows that β-Elemene suppresses MDI-induced lipid accumulation in 3T3-L1 cells, improves glucose consumption in a dexamethasone-induced insulin-resistance model, and restores AMPK pathway activity. Its main contribution is a cell-based mechanistic framework connecting a natural sesquiterpene with adipocyte differentiation and metabolic regulation, while also identifying the experiments needed to test whether AMPK is causally required.

DMG-PEG2000-NH2: A Design Guide for TB Delivery

2026-09-05

DMG-PEG2000-NH2 is an NH2-PEG derivative that connects lipid-platform engineering with rational antimycobacterial assay design. This guide explains its amide-coupling chemistry, formulation role, practical controls, and the translational limits of applying sulfonamide SAR insights to advanced delivery systems.